Squarepoint
TMCI icon

Squarepoint’s Treace Medical Concepts TMCI Stock Holding History

Squarepoint’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$282K Buy
+70,801
New +$195K ﹤0.01% 3855
2025
Q4 		– Sell
-28,988
Closed -$195K – 4893
2025
Q3 		$195K Sell
28,988
-19,984
-41% -$130K ﹤0.01% 3958
2025
Q2 		$288K Buy
+48,972
New +$319K ﹤0.01% 3725
2025
Q1 		– Sell
-18,470
Closed -$137K – 5414
2024
Q4 		$137K Sell
18,470
-52,890
-74% -$354K ﹤0.01% 4607
2024
Q3 		$414K Sell
71,360
-46,687
-40% -$300K ﹤0.01% 3241
2024
Q2 		$785K Buy
118,047
+88,577
+301% +$716K ﹤0.01% 2738
2024
Q1 		$385K Sell
29,470
-100,800
-77% -$1.34M ﹤0.01% 3224
2023
Q4 		$1.66M Buy
130,270
+13,476
+12% +$136K ﹤0.01% 2141
2023
Q3 		$1.53M Buy
116,794
+99,359
+570% +$1.82M ﹤0.01% 2020
2023
Q2 		$446K Sell
17,435
-46,399
-73% -$1.2M ﹤0.01% 2690
2023
Q1 		$1.61M Buy
63,834
+13,679
+27% +$321K 0.01% 1566
2022
Q4 		$1.15M Buy
+50,155
New +$1.15M ﹤0.01% 1729

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Squarepoint's TMCI Position: Q2 2026 in Review

Squarepoint opened a new position in Treace Medical Concepts (TMCI) in Q2 2026: 70,801 shares worth $282K. The stake represents ﹤0.01% of the portfolio and ranks #3855 among its holdings. This is a return to the name: Squarepoint previously reported a position in TMCI as recently as Q3 2025.

Squarepoint first reported a position in TMCI in Q4 2022 and has held it in 12 quarters since. The position peaked at $1.66M in Q4 2023. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Squarepoint held 70,801 shares of Treace Medical Concepts worth $282K as of Q2 2026.
  • Treace Medical Concepts was a new Squarepoint position in Q2 2026.
  • Treace Medical Concepts made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #3855 holding.
  • Squarepoint first reported a position in Treace Medical Concepts in Q4 2022 and has held it in 12 quarters since.
  • Squarepoint's Treace Medical Concepts position peaked at $1.66M in Q4 2023.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.